A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography.
Completed
- Conditions
- depressionmajor depressive disorder10027946
- Registration Number
- NL-OMON34843
- Lead Sponsor
- PharmaNeuroBoost NV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Healthy males and females
Between 35 and 75 years of age
Exclusion Criteria
Clinical significant abnormalities for medical examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>-</p><br>
- Secondary Outcome Measures
Name Time Method <p>-</p><br>